Quidel (NASDAQ: QDEL) is focused on the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. The company markets its products under the QuickVue®, D3® Direct Detection and Thyretain® leading brand names, as well as under the new Sofia® and Quidel Molecular brands. The products aid in the detection and diagnosis of many critical diseases and conditions. For more information visit the company’s Web site at: www.quidel.com

William Blair & Company is a global investment banking and asset management firm committed to building enduring relationships with clients and providing expertise and solutions to meet their evolving needs. An independent and employee-owned firm, William Blair is based in Chicago, and has office locations in 10 cities, including London, New York, Shanghai, and Zurich. For more information on William Blair & Company, visit www.williamblair.com

Let us hear your thoughts below: